Influenza Virus Assembly and Budding at the Viral Budozone

Advances in Virus Research

Volumn 64, Issue , 2005, Pages 383-416

  Schmitt, Anthony P ^a   Lamb, Robert A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS PROTEIN;

ANIMAL; ARTICLE; HUMAN; METABOLISM; ORTHOMYXOVIRUS; PHYSIOLOGY; PROTEIN TRANSPORT; VIRUS ASSEMBLY; VIRUS NUCLEOCAPSID; VIRUS REPLICATION;

ANIMALS; HUMANS; NUCLEOCAPSID; ORTHOMYXOVIRIDAE; PROTEIN TRANSPORT; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 26944491901     PISSN: 00653527     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-3527(05)64012-2     Document Type: Review

References (153)

1. Ali A., Avalos R.T., Ponimaskin E., and Nayak D.P. Influenza virus assembly: Effect of influenza virus glycoproteins on the membrane association of M1 protein. J. Virol. 74 (2000) 8709-8719
2. Area E., Martin-Benito J., Gastaminza P., Torreira E., Valpuesta J.M., Carrascosa J.L., and Ortin J. 3D structure of the influenza virus polymerase complex: Localization of subunit domains. Proc. Natl. Acad. Sci. USA 101 (2004) 308-313
3. Arzt S., Baudin F., Barge A., Timmins P., Burmeister W.P., and Ruigrok R.W. Combined results from solution studies on intact influenza virus M1 protein and from a new crystal form of its N-terminal domain show that M1 is an elongated monomer. Virology 279 (2001) 439-446
4. Arzt S., Petit I., Burmeister W.P., Ruigrok R.W., and Baudin F. Structure of a knockout mutant of influenza virus M1 protein that has altered activities in membrane binding, oligomerisation and binding to NEP (NS2). Virus Res. 99 (2004) 115-119
5. Avalos R.T., Yu Z., and Nayak D.P. Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J. Virol. 71 (1997) 2947-2958
6. Barman S., Adhikary L., Chakrabarti A.K., Bernas C., Kawaoka Y., and Nayak D.P. Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. J. Virol. 78 (2004) 5258-5269
7. Barman S., Adhikary L., Kawaoka Y., and Nayak D.P. Influenza A virus hemagglutinin containing basolateral localization signal does not alter the apical budding of a recombinant influenza A virus in polarized MDCK cells. Virology 305 (2003) 138-152
8. Barman S., Ali A., Hui E.K., Adhikary L., and Nayak D.P. Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res. 77 (2001) 61-69
9. Barman S., and Nayak D.P. Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association. J. Virol. 74 (2000) 6538-6545
10. Baudin F., Petit I., Weissenhorn W., and Ruigrok R.W. In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 281 (2001) 102-108
11. Bourmakina S.V., and Garcia-Sastre A. Reverse genetics studies on the filamentous morphology of influenza A virus. J. Gen. Virol. 84 (2003) 517-527
12. Brewer C.B., and Roth M.G. A single amino acid change in the cytoplasmic domain alters the polarized delivery of influenza virus hemagglutinin. J. Cell Biol. 114 (1991) 413-421
13. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275 (2000) 17221-17224
14. Brown E.L., and Lyles D.S. A novel method for analysis of membrane microdomains: Vesicular stomatitis virus glycoprotein microdomains change in size during infection, and those outside of budding sites resemble sites of virus budding. Virology 310 (2003) 343-358
15. Bucher D., Popple S., Baer M., Mikhail A., Gong Y.F., Whitaker C., Paoletti E., and Judd A. M protein (M1) of influenza virus: Antigenic analysis and intracellular localization with monoclonal antibodies. J. Virol. 63 (1989) 3622-3633
16. Bucher D.J., Kharitonenkov I.G., Zakomirdin J.A., Grigoriev V.B., Klimenko S.M., and Davis J.F. Incorporation of influenza virus M-protein into liposomes. J. Virol. 36 (1980) 586-590
17. Bui M., Whittaker G., and Helenius A. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 70 (1996) 8391-8401
18. Bui M., Wills E.G., Helenius A., and Whittaker G.R. Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J. Virol. 74 (2000) 1781-1786
19. Chazal N., and Gerlier D. Virus entry, assembly, budding, and membrane rafts. Microbiol. Mol. Biol. Rev. 67 (2003) 226-237
20. Choppin P.W., Murphy J.S., and Tamm I. Studies of two kinds of virus particles which comprise influenza A2 virus strains. III. Morphological characteristics: Independence to morphological and functional traits. J. Exp. Med. 112 (1960) 945-952
21. Chu C.M., Dawson I.M., and Elford W.J. Filamentous forms associated with newly isolated influenza virus. Lancet 1 (1949) 602-603
22. Compans R.W. Virus entry and release in polarized epithelial cells. Curr. Top. Microbiol. Immunol. 202 (1995) 209-219
23. Compans R.W., Content J., and Duesberg P.H. Structure of the ribonucleoprotein of influenza virus. J. Virol. 10 (1972) 795-800
24. Craven R.C., Harty R.N., Paragas J., Palese P., and Wills J.W. Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J. Virol. 73 (1999) 3359-3365
25. Elleman C.J., and Barclay W.S. The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321 (2004) 144-153
26. Elster C., Larsen K., Gagnon J., Ruigrok R.W., and Baudin F. Influenza virus M1 protein binds to RNA through its nuclear localization signal. J. Gen. Virol. 78 (1997) 1589-1596
27. Elton D., Simpson-Holley M., Archer K., Medcalf L., Hallam R., McCauley J., and Digard P. Interaction of the influenza virus nucleoprotein with the cellular CRM1-mediated nuclear export pathway. J. Virol. 75 (2001) 408-419
28. Enami M., and Enami K. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 70 (1996) 6653-6657
29. Enami M., Sharma G., Benham C., and Palese P. An influenza virus containing nine different RNA segments. Virology 185 (1991) 291-298
30. Freed E.O. Viral late domains. J. Virol. 76 (2002) 4679-4687
31. Fujii Y., Goto H., Watanabe T., Yoshida T., and Kawaoka Y. Selective incorporation of influenza virus RNA segments into virions. Proc. Natl. Acad. Sci. USA 100 (2003) 2002-2007
32. Garcia-Sastre A., Muster T., Barclay W.S., Percy N., and Palese P. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J. Virol. 68 (1994) 6254-6261
33. Garcia-Sastre A., and Palese P. The cytoplasmic tail of the neuraminidase protein of influenza A virus does not play an important role in the packaging of this protein into viral envelopes. Virus Res. 37 (1995) 37-47
34. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M., Rich R.L., Myszka D.G., and Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107 (2001) 55-65
35. Gomez-Puertas P., Albo C., Perez-Pastrana E., Vivo A., and Portela A. Influenza virus matrix protein is the major driving force in virus budding. J. Virol. 74 (2000) 11538-11547
36. Gomez-Puertas P., Mena I., Castillo M., Vivo A., Perez-Pastrana E., and Portela A. Efficient formation of influenza virus-like particles: Dependence on the expression levels of viral proteins. J. Gen. Virol. 80 (1999) 1635-1645
37. Gottlinger H.G., Dorfman T., Sodroski J.G., and Haseltine W.A. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc. Natl. Acad. Sci. USA 88 (1991) 3195-3199
38. Gregoriades A. Interaction of influenza M protein with viral lipid and phosphatidylcholine vesicles. J. Virol. 36 (1980) 470-479
39. Gregoriades A., and Frangione B. Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. J. Virol. 40 (1981) 323-328
40. Harris A., Forouhar F., Qiu S., Sha B., and Luo M. The crystal structure of the influenza matrix protein M1 at neutral pH: M1-M1 protein interfaces can rotate in the oligomeric structures of M1. Virology 289 (2001) 34-44
41. Harty R.N., Brown M.E., McGettigan J.P., Wang G., Jayakar H.R., Huibregtse J.M., Whitt M.A., and Schnell M.J. Rhabdoviruses and the cellular ubiquitin-proteasome system: A budding interaction. J. Virol. 75 (2001) 10623-10629
42. Harty R.N., Brown M.E., Wang G., Huibregtse J., and Hayes F.P. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding. Proc. Natl. Acad. Sci. USA 97 (2000) 13871-13876
43. Harty R.N., Paragas J., Sudol M., and Palese P. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: Implications for viral budding. J. Virol. 73 (1999) 2921-2929
44. 2 ion channel protein. Semin. Virol. 3 (1992) 21-30
45. Heggeness M.H., Smith P.R., Ulmanen I., Krug R.M., and Choppin P.W. Studies on the helical nucleocapsid of influenza virus. Virology 118 (1982) 466-470
46. Helenius A. Unpacking the incoming influenza virus. Cell 69 (1992) 577-578
47. Horimoto T., Takada A., Iwatsuki-Horimoto K., Hatta M., Goto H., and Kawaoka Y. Generation of influenza A viruses with chimeric (type A/B) hemagglutinins. J. Virol. 77 (2003) 8031-8038
48. Huang M., Orenstein J.M., Martin M.A., and Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 69 (1995) 6810-6818
49. Huang X., Liu T., Muller J., Levandowski R.A., and Ye Z. Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export. Virology 287 (2001) 405-416
50. Hughes M.T., Matrosovich M., Rodgers M.E., McGregor M., and Kawaoka Y. Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice. J. Virol. 74 (2000) 5206-5212
51. Hughes M.T., McGregor M., Suzuki T., Suzuki Y., and Kawaoka Y. Adaptation of influenza A viruses to cells expressing low levels of sialic acid leads to loss of neuraminidase activity. J. Virol. 75 (2001) 3766-3770
52. Hughey P.G., Compans R.W., Zebedee S.L., and Lamb R.A. Expression of the influenza A virus M2 protein is restricted to apical surfaces of polarized epithelial cells. J. Virol. 66 (1992) 5542-5552
53. Hui E.K., Barman S., Yang T.Y., and Nayak D.P. Basic residues of the helix six domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by PTAP and YPDL late assembly domain motifs. J. Virol. 77 (2003) 7078-7092
54. Hui E.K., and Nayak D.P. Role of ATP in influenza virus budding. Virology 290 (2001) 329-341
55. Jayakar H.R., Murti K.G., and Whitt M.A. Mutations in the PPPY motif of vesicular stomatitis virus matrix protein reduce virus budding by inhibiting a late step in virion release. J. Virol. 74 (2000) 9818-9827
56. Jin H., Leser G.P., and Lamb R.A. The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J. 13 (1994) 5504-5515
57. Jin H., Leser G.P., Zhang J., and Lamb R.A. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J. 16 (1997) 1236-1247
58. Jones L.V., Compans R.W., Davis A.R., Bos T.J., and Nayak D.P. Surface expression of influenza virus neuraminidase, an amino-terminally anchored viral membrane glycoprotein, in polarized epithelial cells. Mol. Cell. Biol. 5 (1985) 2181-2189
59. Khor R., McElroy L.J., and Whittaker G.R. The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 4 (2003) 857-868
60. Kikonyogo A., Bouamr F., Vana M.L., Xiang Y., Aiyar A., Carter C., and Leis J. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for Gag budding from cells. Proc. Natl. Acad. Sci. USA 98 (2001) 11199-11204
61. Kilbourne E.D., and Murphy J.S. Genetic studies of influenza viruses. I. Viral morphology and growth capacity as exchangeable genetic traits: Rapid in ovo adaptation of early passage Asian strain isolates by combination with PR8. J. Exp. Med. 111 (1960) 387-406
62. Kretzschmar E., Bui M., and Rose J.K. Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology 220 (1996) 37-45
63. Kundu A., Avalos R.T., Sanderson C.M., and Nayak D.P. Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells. J. Virol. 70 (1996) 6508-6515
64. Lamb R.A., and Choppin P.W. The gene structure and replication of influenza virus. Annu. Rev. Biochem. 52 (1983) 467-506
65. Lamb R.A., and Krug R.M. Orthomyxoviridae: The viruses and their replication. In: Knipe D., and Howley P. (Eds). "Field's Virology". 4th Ed. (2001), Lippincott Williams & Wilkins, Philadelphia, PA 1487-1532
66. 2 ion channel protein and its role in the influenza virus life cycle. In: Wimmer E. (Ed). "Receptor-mediated virus entry into cells" (1994), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 303-321
67. Latham T., and Galarza J.M. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J. Virol. 75 (2001) 6154-6165
68. Li S., Xu M., and Coelingh K. Electroporation of influenza virus ribonucleoprotein complexes for rescue of the nucleoprotein and matrix genes. Virus Res. 37 (1995) 153-161
69. Licata J.M., Simpson-Holley M., Wright N.T., Han Z., Paragas J., and Harty R.N. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: Involvement of host proteins TSG101 and VPS-4. J. Virol. 77 (2003) 1812-1819
70. Lin S., Naim H.Y., Rodriguez A.C., and Roth M.G. Mutations in the middle of the transmembrane domain reverse the polarity of transport of the influenza virus hemagglutinin in MDCK epithelial cells. J. Cell Biol. 142 (1998) 51-57
71. Liu C., and Air G.M. Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 194 (1993) 403-407
72. Liu C., Eichelberger M.C., Compans R.W., and Air G.M. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol. 69 (1995) 1099-1106
73. Liu T., Muller J., and Ye Z. Association of influenza virus matrix protein with ribonucleoproteins may control viral growth and morphology. Virology 304 (2002) 89-96
74. Liu T., and Ye Z. Restriction of viral replication by mutation of the influenza virus matrix protein. J. Virol. 76 (2002) 13055-13061
75. Lohmeyer J., Talens L.T., and Klenk H.D. Biosynthesis of the influenza virus envelope in abortive infection. J. Gen. Virol. 42 (1979) 73-88
76. Luytjes W., Krystal M., Enami M., Pavin J.D., and Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell 59 (1989) 1107-1113
77. Maisner A., Klenk H., and Herrler G. Polarized budding of measles virus is not determined by viral surface glycoproteins. J. Virol. 72 (1998) 5276-5278
78. Martin K., and Helenius A. Nuclear transport of influenza virus ribonucleoproteins: The viral matrix protein (M1) promotes export and inhibits import. Cell 67 (1991) 117-130
79. Martin-Benito J., Area E., Ortega J., Llorca O., Valpuesta J.M., Carrascosa J.L., and Ortin J. Three-dimensional reconstruction of a recombinant influenza virus ribonucleoprotein particle. EMBO Rep. 2 (2001) 313-317
80. Martin-Serrano J., Perez-Caballero D., and Bieniasz P.D. Context-dependent effects of L domains and ubiquitination on viral budding. J. Virol. 78 (2004) 5554-5563
81. Martin-Serrano J., Yarovoy A., Perez-Caballero D., and Bieniasz P.D. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. USA 100 (2003) 12414-12419
82. Martin-Serrano J., Zang T., and Bieniasz P.D. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7 (2001) 1313-1319
83. Mena I., Vivo A., Perez E., and Portela A. Rescue of a synthetic chloramphenicol acetyltransferase RNA into influenza virus-like particles obtained from recombinant plasmids. J. Virol. 70 (1996) 5016-5024
84. Mitnaul L.J., Castrucci M.R., Murti K.G., and Kawaoka Y. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J. Virol. 70 (1996) 873-879
85. Moll M., Klenk H.D., Herrler G., and Maisner A. A single amino acid change in the cytoplasmic domains of measles virus glycoproteins H and F alters targeting, endocytosis, and cell fusion in polarized Madin-Darby canine kidney cells. J. Biol. Chem. 276 (2001) 17887-17894
86. Mora R., Rodriguez-Boulan E., Palese P., and Garcia-Sastre A. Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal. J. Virol. 76 (2002) 3544-3553
87. Munro S. Lipid rafts: Elusive or illusive?. Cell 115 (2003) 377-388
88. Murti K.G., Brown P.S., Bean Jr. W.J., and Webster R.G. Composition of the helical internal components of influenza virus as revealed by immunogold labeling/electron microscopy. Virology 186 (1992) 294-299
89. Murti K.G., Webster R.G., and Jones I.M. Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology 164 (1988) 562-566
90. Naim H.Y., Ehler E., and Billeter M.A. Measles virus matrix protein specifies apical virus release and glycoprotein sorting in epithelial cells. EMBO J. 19 (2000) 3576-3585
91. Naim H.Y., and Roth M.G. Basis for selective incorporation of glycoproteins into the influenza virus envelope. J. Virol. 67 (1993) 4831-4841
92. Nayak D.P., and Barman S. Role of lipid rafts in virus assembly and budding. Adv. Virus Res. 58 (2002) 1-28
93. Nermut M.V. Further investigation on the fine structure of influenza virus. J. Gen. Virol. 17 (1972) 317-331
94. Neumann G., Hughes M.T., and Kawaoka Y. Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J. 19 (2000) 6751-6758
95. Neumann G., Watanabe T., and Kawaoka Y. Plasmid-driven formation of influenza virus-like particles. J. Virol. 74 (2000) 547-551
96. O'Neill R.E., Talon J., and Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 17 (1998) 288-296
97. Palese P., Tobita K., Ueda M., and Compans R.W. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology 61 (1974) 397-410
98. Patnaik A., Chau V., and Wills J.W. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. USA 97 (2000) 13069-13074
99. Pons M.W., Schulze I.T., Hirst G.K., and Hauser R. Isolation and characterization of the ribonucleoprotein of influenza virus. Virology 39 (1969) 250-259
100. Pornillos O., Garrus J.E., and Sundquist W.I. Mechanisms of enveloped RNA virus budding. Trends Cell Biol. 12 (2002) 569-579
101. Pralle A., Keller P., Florin E.L., Simons K., and Horber J.K. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell Biol. 148 (2000) 997-1008
102. Puffer B.A., Parent L.J., Wills J.W., and Montelaro R.C. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J. Virol. 71 (1997) 6541-6546
103. Rey O., and Nayak D.P. Nuclear retention of M1 protein in a temperature-sensitive mutant of influenza (A/WSN/33) virus does not affect nuclear export of viral ribonucleoproteins. J. Virol. 66 (1992) 5815-5824
104. Roberts P.C., and Compans R.W. Host cell dependence of viral morphology. Proc. Natl. Acad. Sci. USA 95 (1998) 5746-5751
105. Roberts P.C., Lamb R.A., and Compans R.W. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240 (1998) 127-137
106. Rodriguez-Boulan E., and Sabatini D.D. Asymmetric budding of viruses in epithelial monlayers: A model system for study of epithelial polarity. Proc. Natl. Acad. Sci. USA 75 (1978) 5071-5075
107. Roth M.G., Compans R.W., Giusti L., Davis A.R., Nayak D.P., Gething M.J., and Sambrook J. Influenza virus hemagglutinin expression is polarized in cells infected with recombinant SV40 viruses carrying cloned hemagglutinin DNA. Cell 33 (1983) 435-443
108. Ruigrok R.W., Barge A., Durrer P., Brunner J., Ma K., and Whittaker G.R. Membrane interaction of influenza virus M1 protein. Virology 267 (2000) 289-298
109. Ruigrok R.W., Calder L.J., and Wharton S.A. Electron microscopy of the influenza virus submembranal structure. Virology 173 (1989) 311-316
110. Sanger C., Muhlberger E., Ryabchikova E., Kolesnikova L., Klenk H.D., and Becker S. Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells. J. Virol. 75 (2001) 1274-1283
111. Scheiffele P., Rietveld A., Wilk T., and Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274 (1999) 2038-2044
112. Scheiffele P., Roth M.G., and Simons K. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J. 16 (1997) 5501-5508
113. Schmitt A.P., and Lamb R.A. Escaping from the cell: Assembly and budding of negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283 (2004) 145-196
114. Schubert U., Ott D.E., Chertova E.N., Welker R., Tessmer U., Princiotta M.F., Bennink J.R., Krausslich H.G., and Yewdell J.W. Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. USA 97 (2000) 13057-13062
115. Schulze I.T. The structure of influenza virus. II. A model based on the morphology and composition of subviral particles. Virology 47 (1972) 181-196
116. Sha B., and Luo M. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4 (1997) 239-244
117. Shibata S., Yamamoto-Goshima F., Maeno K., Hanaichi T., Fujita Y., Nakajima K., Imai M., Komatsu T., and Sugiura S. Characterization of a temperature-sensitive influenza B virus mutant defective in neuraminidase. J. Virol. 67 (1993) 3264-3273
118. Shinya K., Fujii Y., Ito H., Ito T., and Kawaoka Y. Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine. J. Virol. 78 (2004) 3083-3088
119. Simons K., and Ikonen E. Functional rafts in cell membranes. Nature 387 (1997) 569-572
120. Simpson-Holley M., Ellis D., Fisher D., Elton D., McCauley J., and Digard P. A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions. Virology 301 (2002) 212-225
121. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: The influenza hemagglutinin. Annu. Rev. Biochem. 69 (2000) 531-569
122. Skibbens J.E., Roth M.G., and Matlin K.S. Differential extractability of influenza virus hemagglutinin during intracellular transport in polarized epithelial cells and nonpolar fibroblasts. J. Cell Biol. 108 (1989) 821-832
123. Smirnov Y.A., Kuznetsova M.A., and Kaverin N.V. The genetic aspects of influenza virus filamentous particle formation. Arch. Virol. 118 (1991) 279-284
124. Strack B., Calistri A., Craig S., Popova E., and Gottlinger H.G. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114 (2003) 689-699
125. Sugrue R.J., and Hay A.J. Structural characteristics of the M2 protein of influenza A viruses: Evidence that it forms a tetrameric channel. Virology 180 (1991) 617-624
126. Suomalainen M. Lipid rafts and assembly of enveloped viruses. Traffic 3 (2002) 705-709
127. Takeda M., Leser G.P., Russell C.J., and Lamb R.A. Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc. Natl. Acad. Sci. USA 100 (2003) 14610-14617
128. 2 ion channel activity is essential for efficient replication in tissue culture. J. Virol. 76 (2002) 1391-1399
129. Tall R.D., Alonso M.A., and Roth M.G. Features of influenza HA required for apical sorting differ from those required for association with DRMs or MAL. Traffic 4 (2003) 838-849
130. Tashiro M., Yamakawa M., Tobita K., Seto J.T., Klenk H.D., and Rott R. Altered budding site of a pantropic mutant of Sendai virus, F1-R, in polarized epithelial cells. J. Virol. 64 (1990) 4672-4677
131. Thomas D.C., and Roth M.G. The basolateral targeting signal in the cytoplasmic domain of glycoprotein G from vesicular stomatitis virus resembles a variety of intracellular targeting motifs related by primary sequence but having diverse targeting activities. J. Biol. Chem. 269 (1994) 15732-15739
132. Timmins J., Schoehn G., Ricard-Blum S., Scianimanico S., Vernet T., Ruigrok R.W., and Weissenhorn W. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 326 (2003) 493-502
133. Varma R., and Mayor S. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394 (1998) 798-801
134. VerPlank L., Bouamr F., LaGrassa T.J., Agresta B., Kikonyogo A., Leis J., and Carter C.A. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc. Natl. Acad. Sci. USA 98 (2001) 7724-7729
135. Vincent O., Rainbow L., Tilburn J., Arst Jr. H.N., and Penalva M.A. YPXL/I is a protein interaction motif recognized by Aspergillus PalA and its human homologue, AIP1/Alix. Mol. Cell. Biol. 23 (2003) 1647-1655
136. von Schwedler U.K., Stuchell M., Muller B., Ward D.M., Chung H.Y., Morita E., Wang H.E., Davis T., He G.P., Cimbora D.M., Scott A., Krausslich H.G., Kaplan J., Morham S.G., and Sundquist W.I. The protein network of HIV budding. Cell 114 (2003) 701-713
137. Wakefield L., and Brownlee G.G. RNA-binding properties of influenza A virus matrix protein M1. Nucleic Acids Res. 17 (1989) 8569-8580
138. Watanabe K., Handa H., Mizumoto K., and Nagata K. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J. Virol. 70 (1996) 241-247
139. Watanabe T., Watanabe S., Neumann G., Kida H., and Kawaoka Y. Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles. J. Virol. 76 (2002) 767-773
140. Watanabe T., Watanabe S., Noda T., Fujii Y., and Kawaoka Y. Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J. Virol. 77 (2003) 10575-10583
141. Whittaker G., Bui M., and Helenius A. The role of nuclear import and export in influenza virus infection. Trends Cell Biol. 6 (1996) 67-71
142. Wills J.W., Cameron C.E., Wilson C.B., Xiang Y., Bennett R.P., and Leis J. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J. Virol. 68 (1994) 6605-6618
143. Xiang Y., Cameron C.E., Wills J.W., and Leis J. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J. Virol. 70 (1996) 5695-5700
144. Yang P., Bansal A., Liu C., and Air G.M. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses. Virology 229 (1997) 155-165
145. Ye Z.P., Baylor N.W., and Wagner R.R. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 63 (1989) 3586-3594
146. Ye Z., Liu T., Offringa D.P., McInnis J., and Levandowski R.A. Association of influenza virus matrix protein with ribonucleoproteins. J. Virol. 73 (1999) 7467-7473
147. Ye Z.P., Pal R., Fox J.W., and Wagner R.R. Functional and antigenic domains of the matrix (M1) protein of influenza A virus. J. Virol. 61 (1987) 239-246
148. Ye Z., Robinson D., and Wagner R.R. Nucleus-targeting domain of the matrix protein (M1) of influenza virus. J. Virol. 69 (1995) 1964-1970
149. Zebedee S.L., and Lamb R.A. Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virions. J. Virol. 62 (1988) 2762-2772
150. Zhang J., and Lamb R.A. Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology 225 (1996) 255-266
151. Zhang J., Leser G.P., Pekosz A., and Lamb R.A. The cytoplasmic tails of the influenza virus spike glycoproteins are required for normal genome packaging. Virology 269 (2000) 325-334
152. Zhang J., Pekosz A., and Lamb R.A. Influenza virus assembly and lipid raft microdomains: A role for the cytoplasmic tails of the spike glycoproteins. J. Virol. 74 (2000) 4634-4644
153. Zhirnov O.P. Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology 186 (1992) 324-330